-
Electronic (PDF)
-
Site License
-
Enterprisewide
Health Discovery Corporation (HDVY) - Product Pipeline Analysis
GlobalData, November 2012, Pages: 30
Summary
Health Discovery Corporation (HDC) is a pharmaceutical company, based in the US. The company provides medicine and biomarker discovery. It provides gene based tests for the detection of various types of cancers such as prostate cancer, colon cancer, leukemia; and AIDS. HDC develops products using its key technologies that include support vector machine, recursive feature elimination, fractal genomic modeling and independent validations. The company also licenses its breast cancer diagnostic technologies such as MammoSIGHT for detecting malignancy in mammograms and MetastaSIGHT for identifying circulating tumor cells in the blood. HDC is headquartered in Savannah, Georgia, the US.
This report is a source for data, analysis and actionable intelligence on the Health Discovery Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
List of Tables
List of Figures
Key Facts
Health Discovery Corporation - Major Products and Services
Health Discovery Corporation Pipeline Products by Equipment Type
Health Discovery Corporation Pipeline Products by Development Stage
Health Discovery Corporation Pipeline Products by Therapy Area
Health Discovery Corporation Pipeline Products by Milestone Summary
Diagnostic Test - Colon Cancer
Diagnostic Test - Colon Cancer Product Status
Diagnostic Test - Colon Cancer Product Description
Diagnostic Test - Colon Cancer Product Milestone
Product Institution Details
Diagnostic Test - Pancreatic Cancer
Diagnostic Test - Pancreatic Cancer Product Status
Diagnostic Test - Pancreatic Cancer Product Description
Diagnostic Test - Pancreatic Cancer Product Milestone
Diagnostic Test - Pancreatic Cancer Product Patent Details
Product Institution Details
Diagnostic Test - Pre-Leukemia
Diagnostic Test - Pre-Leukemia Product Status
Diagnostic Test - Pre-Leukemia Product Description
Diagnostic Test - Pre-Leukemia Product Milestone
Health Discovery Corporation - Key Competitors
Health Discovery Corporation - Key Employees
Health Discovery Corporation - Locations And Subsidiaries
Head Office
Recent Developments
Health Discovery Corporation, Recent Developments
Oct 23, 2012: Health Discovery Announces Resignation Of Stephen Barnhill As CEO
Aug 14, 2012: Health Discovery Reports Q2 2012 Results
May 15, 2012: Health Discovery Reports Q1 2012 Results
Mar 30, 2012: Health Discovery Reports 2011 Results
Feb 01, 2012: Health Discovery Launches Android Version Of MelApp, Melanoma Risk Analysis Mobile Phone App
Nov 14, 2011: Health Discovery Reports Q3 2011 Results
Nov 09, 2011: Health Discovery Appoints John Hadden As Senior Vice President Of National And International Business Development
Oct 14, 2011: Health Discovery Agrees With USPSTF Against PSA-based Screening For Prostate Cancer
Oct 07, 2011: Health Discovery Issues Update On US And International Developments Relating To Its SVM-RFE Technology Patents
Sep 28, 2011: Health Discovery Announces Issuance Of First Patent Covering Prostate Cancer Biomarkers
Appendix
Methodology
About Us
Contact Us
Disclaimer
List of Tables
Health Discovery Corporation, Key Facts
Health Discovery Corporation Key Pipeline Products by Equipment Type
Health Discovery Corporation Key Pipeline Products by Therapy Area
Health Discovery Corporation Key Pipeline Products by Development Stage
Health Discovery Corporation, Key Facts
Health Discovery Corporation, Major Products and Services
Health Discovery Corporation Number of Pipeline Products by Equipment Type
Health Discovery Corporation Pipeline Products by Equipment Type
Health Discovery Corporation Number of Pipeline Products by Development Stage
Health Discovery Corporation Pipeline Products by Development Stage
Health Discovery Corporation Number of Pipeline Products by Therapy Area
Health Discovery Corporation Pipeline Products by Therapy Area
Health Discovery Corporation Number of Pipeline Products By Milestone Summary
Health Discovery Corporation Pipeline Products by Milestone Summary
Diagnostic Test - Colon Cancer - Product Status
Diagnostic Test - Colon Cancer - Product Description
Diagnostic Test - Colon Cancer - Product Milestone
Diagnostic Test - Pancreatic Cancer - Product Status
Diagnostic Test - Pancreatic Cancer - Product Description
Diagnostic Test - Pancreatic Cancer - Product Milestone
Diagnostic Test - Pancreatic Cancer - Patent Details1
Diagnostic Test - Pancreatic Cancer - Patent Details2
Diagnostic Test - Pancreatic Cancer - Patent Details3
Diagnostic Test - Pre-Leukemia - Product Status
Diagnostic Test - Pre-Leukemia - Product Description
Diagnostic Test - Pre-Leukemia - Product Milestone
Health Discovery Corporation, Key Employees
List of Figures
Health Discovery Corporation Pipeline Products by Equipment Type
Health Discovery Corporation Pipeline Products by Development Stage
Health Discovery Corporation Pipeline Products by Therapy Area
Health Discovery Corporation Pipeline Products by Milestone Summary
Phytomedics, Inc.
Nereus Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
Memgen, LLC.
Neogenix Oncology Corporation
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
